Global digital health funding reached $7.1B in Q2’22 — down 32% from the previous quarter, continuing the decline from record highs in 2021. The decrease in funding and deals affected almost all sectors across digital health except for Health IT, mirroring the broader downtrend in venture funding.

Dig into the report to dive into these key trends and more:

• Amid a global funding slump, Europe was the only region to see a QoQ increase in funding, boosted by Alan‘s $193M Series E mega-round.
• By region, the U.S. raised the most in total digital health funding in Q2’22 ($4.8B), despite a 53% YoY decline.
• Total digital health unicorns broke 100 for the first time ever, even as unicorn births held steady QoQ. New entrants include Oura ($2.6B valuation), Clarify Health ($1.4B), and Biofourmis ($1.3B).

Plus a lot more.

In the full report. Let’s go.